Stearic Acid

Stearic Acid

SCHEMBL1230185

CC(C)[O-].CC(C)[O-].CC(C)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Zr+4]

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.62
CA1 P00915 1/20 0.60
CES2 O00748 4/20 0.56
CES1 P23141 4/20 0.56
NFKB1 P19838 1/20 0.55
GPR84 Q9NQS5 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Palmitic Acid SCHEMBL8111697 1.00 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Hexanoate SCHEMBL1230254 0.98 CA1 (0.62) FABP3CA1CES2CES1NFKB1
Decanoic Acid SCHEMBL6153196 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Stearic Acid SCHEMBL1230619 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Stearic Acid SCHEMBL31364148 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Palmitic Acid SCHEMBL8803956 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Octanoic Acid SCHEMBL6153026 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Stearic Acid SCHEMBL9855948 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Stearic Acid SCHEMBL1228588 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1
Heptanoate SCHEMBL7723609 0.96 FABP3 (0.62) FABP3CA1CES2CES1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1746134-B1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS KANEKA CORP (JP) 2019-09-04 EP disclosed
EP-1746135-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-05-29 EP disclosed
US-7973108-B2 Curable composition KANEKA CORPORATION (JP) 2011-07-05 US disclosed
WO-2011072056-A2 CURE RATE CONTROL FOR ALKOXYSILYL-END-BLOCKED POLYMERS DOW CORNING COPORATION (US) 2011-06-16 WO disclosed
US-7910681-B2 Curable composition having improved adhesion KANEKA CORPORATION (JP) 2011-03-22 US disclosed
US-7893170-B2 Curable composition having improved curability and adhesion KANEKA CORPORATION (JP) 2011-02-22 US disclosed
US-20080319152-A1 Curable Composition KANEKA CORPORATION (JP) 2008-12-25 US disclosed
US-20080194773-A1 Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-08-14 US disclosed
US-20080076878-A1 Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-03-27 US disclosed
EP-1746134-A1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746135-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-01-24 EP disclosed